Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment could save trauma patients faster
Disease control Not yet recruitingThis study tests whether a new shelf-stable blood product (IFC) works faster than the standard cryoprecipitate to stop severe bleeding in trauma patients. About 320 adults with traumatic injuries and low fibrinogen levels will be enrolled. The goal is to see if IFC can be given m…
Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Blood safety study: do antibodies to treated red cells cause harm?
Knowledge-focused Not yet recruitingThis study looks at whether people who have antibodies to a special type of treated red blood cells (INTERCEPT RBCs) might have a reaction when they receive a transfusion of these cells. Ten participants will receive a transfusion and be monitored for side effects, rapid clearanc…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC